Texas Cardiac Arrhythmia Research Foundation
40
0
1
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.0%
2 terminated/withdrawn out of 40 trials
88.2%
+1.7% vs industry average
33%
13 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
The ORCHESTRATE-Myocarditis Registry
Role: collaborator
Esophageal Protection Study: A Multicenter Study
Role: collaborator
Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)
Role: lead
Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation
Role: lead
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)
Role: collaborator
Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF
Role: lead
Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation
Role: lead
Half-normal Saline in Atrial Fibrillation Ablation
Role: lead
Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy
Role: collaborator
Natural History of COVID-19-Related Atrial Fibrillation
Role: lead
Transcatheter Leak Closure With Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures
Role: lead
RF Applications for Residual LAA Leaks
Role: lead
Immune Response Following COVID-19 Vaccination
Role: lead
Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function
Role: lead
Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)
Role: lead
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
Role: lead
Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk
Role: lead
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
Role: lead
Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation
Role: lead
Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation
Role: lead